Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Hi-Tech Pharmacal Co. (NasdaqNM:HITK)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider
Recent Events
July 24Price hit new 52-week high ($15.15)
Location
369 Bayview Avenue
Amityville, NY 11701
Phone: (631) 789-8228
Fax: (631) 789-8429
Email: sgibson@hitechpharm.com
Employees (last reported count): 146
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 41%
·Over the last 6 months:
 · 5 insider sells; 13.0K shares
  (0.7% of insider shares)
·Institutional: 11% (19% of float)
(19 institutions)
·Net Inst. Selling: 113.0K shares (+29.04%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Hi-Tech Pharmacal Co., Inc. is a specialty manufacturer and marketer of prescription, over-the-counter and nutritional products. The Company sells its products in three similar markets: generic pharmaceuticals, branded products and contract manufacturing. The Company markets its generic pharmaceuticals under the brand names H-T and RX Choice. The Company markets a line of branded products primarily for people with Diabetes, including Diabetic Tussin, DiabetiDerm, DiabetiSweet, DiabetiGest and DiabetiRinse. In addition, the Company markets other niche over-the-counter brands to the general healthcare marketplace under such brands as Kosher Care, Nasal Ease and Soothing Comfort. The Company specializes in the manufacture of liquid, cream and ointment formulations. It also manufactures products in a state-of-the-art sterile facility capable of producing ophthalmic, otic and inhalation products. Hi-Tech Pharmacal markets more than 70 products to approximately 100 customers.
More from Market Guide: Expanded Business Description

Financial Summary
Hi-Tech Pharmacal Co. develops, manufactures and markets over-the-counter, prescription and nutritional products. The Company also produces sterile ophthalmic, otic and inhalation products and provides contract services. For the fiscal year ended 4/30/01, net sales rose 12% to $29.6 million. Net income rose 41% to $2.4 million. Results reflect increased shipments to existing customers, the addition of new customers and higher margins due to changes in sales mix.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2001 Pay

Bernard Seltzer, 77
Chairman
$252K
David Seltzer, 41
Pres, CEO, Sec., Treasurer, Director
449K
Arthur Goldberg, 59
CFO, VP-Fin.
132K
Elan Bar-Giora, 57
Exec. VP- Operations
172K
Dollar amounts are as of 30-Apr-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:HITKAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Sep-2000
$3.25 
Recent Price$8.97 
52-Week High
on 24-July-2001
$15.15 
Beta-0.02 
Daily Volume (3-month avg)82.5K
Daily Volume (10-day avg)32.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+111.1%
52-Week Change
relative to S&P500
+183.1%
Share-Related Items
Market Capitalization$41.0M
Shares Outstanding4.57M
Float2.70M
Dividends & Splits
Annual Dividendnone 
Last Split: 3 for 2 on 2-Nov-1993
Per-Share Data
Book Value (mrq)$4.84 
Earnings (ttm)$0.54 
Earnings (mrq)$0.21 
Sales (ttm)$6.72 
Cash (mrq)$1.65 
Valuation Ratios
Price/Book (mrq)1.85 
Price/Earnings (ttm)16.58 
Price/Sales (ttm)1.33 
Income Statements
Sales (ttm)$29.6M
EBITDA (ttm)$4.02M
Income available to common (ttm)$2.39M
Profitability
Profit Margin (ttm)8.1%
Operating Margin (ttm)13.2%
Fiscal Year
Fiscal Year EndsApr 30
Most recent quarter30-Apr-2001
Management Effectiveness
Return on Assets (ttm)9.25%
Return on Equity (ttm)12.18%
Financial Strength
Current Ratio (mrq)3.56 
Debt/Equity (mrq)0.03 
Total Cash (mrq)$7.14M
Short Interest
As of 8-Aug-2001
Shares Short1,000 
Percent of Float0.0%
Shares Short
(Prior Month)
1,000 
Short Ratio0.01 
Daily Volume119.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-Apr-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.